Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill M Kramer

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Cytokine|March 25, 2014
Early events in Sjögren's Syndrome pathogenesis: the importance of innate immunity in disease initiationJill M Kramer
The New York State Dental Journal|February 25, 2015
Current concepts in Sjögren's syndrome and considerations for the dental practitionerJill M Kramer
Journal of Immunology Research|January 24, 2019
Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren's SyndromeJeremy Kiripolsky, Jill M Kramer
Frontiers in Immunology|May 11, 2026
TLR7 and TLR9 have overlapping but distinct roles in systemic lupus erythematosus and Sjögren's diseaseSheta Biswas, Jill M Kramer
Frontiers in Dental Medicine|February 7, 2025
Sex-specific differences in primary Sjögren's diseaseAchamaporn Punnanitinont, Jill M Kramer
Experimental and Molecular Pathology|September 8, 2014
Molecular concepts in the pathogenesis of ameloblastoma: implications for therapeuticsTania Jhamb, Jill M Kramer
Journal of Periodontology|June 2, 2007
Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapyJill M Kramer, Sarah L Gaffen
Journal of Leukocyte Biology|August 2, 2013
CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesisJill M Kramer, Ekaterina Klimatcheva, Thomas L Rothstein
Clinical Immunology (Orlando, Fla.)|April 12, 2017
Innate immunity in Sjögren's syndromeJeremy Kiripolsky, Liam G McCabe, Jill M Kramer
Journal of Leukocyte Biology|February 19, 2019
Danger signals in oral cavity-related diseasesJason G Kay, Jill M Kramer, Michelle B Visser
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Cytokine|March 25, 2014
Early events in Sjögren's Syndrome pathogenesis: the importance of innate immunity in disease initiationJill M Kramer
The New York State Dental Journal|February 25, 2015
Current concepts in Sjögren's syndrome and considerations for the dental practitionerJill M Kramer
Journal of Immunology Research|January 24, 2019
Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren's SyndromeJeremy Kiripolsky, Jill M Kramer
Frontiers in Immunology|May 11, 2026
TLR7 and TLR9 have overlapping but distinct roles in systemic lupus erythematosus and Sjögren's diseaseSheta Biswas, Jill M Kramer
Frontiers in Dental Medicine|February 7, 2025
Sex-specific differences in primary Sjögren's diseaseAchamaporn Punnanitinont, Jill M Kramer
Experimental and Molecular Pathology|September 8, 2014
Molecular concepts in the pathogenesis of ameloblastoma: implications for therapeuticsTania Jhamb, Jill M Kramer
Journal of Periodontology|June 2, 2007
Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapyJill M Kramer, Sarah L Gaffen
Journal of Leukocyte Biology|August 2, 2013
CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesisJill M Kramer, Ekaterina Klimatcheva, Thomas L Rothstein
Clinical Immunology (Orlando, Fla.)|April 12, 2017
Innate immunity in Sjögren's syndromeJeremy Kiripolsky, Liam G McCabe, Jill M Kramer
Journal of Leukocyte Biology|February 19, 2019
Danger signals in oral cavity-related diseasesJason G Kay, Jill M Kramer, Michelle B Visser
Pageof 5